The evidence for rapamycin as a longevity drug in healthy adults is insufficient

Monitoring and prevention of adverse effects from medications.

Aerobic exercise, strength training, weightlifting, gymnastics, and fitness modalities.

Low-dose rapamycin as an off-label longevity intervention, clinical evidence, and safety debates.

Important questions or areas in which available evidence is insufficient, inconsistent, outdated, or absent.